Abstract
Sarcoidosis is a heterogeneous disease with various treatment indications. Although it affects mainly the lungs, sarcoidosis can affect every organ, especially when the disease course is chronic and protracted. Regular patient follow-up is recommended for early recognition of active, ongoing organ-specific granulomatous inflammation to avoid progression to irreversible fibrosis. In this review, we elaborate on treatment indications and various anti-sarcoidosis regimens proven useful in clinical trials. We also review specialized treatment of specific disease manifestations, with a focus on cardiac sarcoidosis. We also report on treatment for special conditions such as fatigue and small fiber neuropathy. Treatment for sarcoidosis is an emerging landscape, with new data complementing the existing knowledge.
Author supplied keywords
Cite
CITATION STYLE
Papanikolaou, I. C., Antonakis, E., & Pandi, A. (2022). State-of-the-Art Treatments for Sarcoidosis. Methodist DeBakey Cardiovascular Journal. Houston Methodist Debakey Heart and Vascular Center. https://doi.org/10.14797/mdcvj.1068
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.